Research Symposium
PROGRAMME
|
WEDNESDAY: DAY 1 SESSION 1 Chair: Dr. S. Khamanga
|
||
|
14.00-14.15 |
OPENING ADDRESS: PROF. R.B. WALKER |
|
|
14.15-14.30 |
Lucie Allan |
What was the dispute really about? The legal challenge to the pharmacy dispensing fee regulations in South Africa |
|
14.30-14.45 |
Samantha Mukozhiwa |
The use of experimental design for the development of a capillary zone electrophoresis method to quantitate captopril in pharmaceuticals |
|
14.45-15.00 |
Nosiphiwe Ngqwala |
Composition of saline greywater along coastal areas of South Africa |
|
15.00-15.15 |
Amanda Siruma |
Maternal health: Assessment, Community Educational Intervention and Evaluation |
|
15.15-15.30 |
Chiedza Zindove |
Development and assessment of sustained release stavudine microcapsules |
|
15.30-16.00 |
TEA |
|
|
WEDNESDAY: DAY 1 SESSION 2 Chair: Ms L. Allan
|
||
|
16.00-16.15 |
Prof. Roy Jobson |
“Advertising and marketing” in South Africa |
|
16.15-16.30 |
Tendai Chanakira |
Development and assessment of mometasone furoate (MF) nanostructured lipid carriers |
|
16.30-16.45 |
Francis Moyo |
Rhodium removal by emulsion liquid membrane using Tri-n-octylamine as an extractant in the remediation of mining waste waters |
|
16.45-17.00 |
Farai Mhaka |
Formulation development and manufacture of captopril beads using extrusion-spheronization |
|
THURSDAY: DAY 2 SESSION 1 Chair: Mr D. Mubare
|
||
|
8.30-8.45 |
ANNOUNCEMENTS |
|
|
8.45-9.00 |
Maynard Chiwakata |
Synthesis of Bioactive Natural Product Probes for Use in Cellular Assays |
|
9.00-9.15 |
Rial Kloppers |
Should botulinum toxin type A (Botox™) be offered to cerebral palsy children in the public sector? |
|
9.15-9.30 |
Faith Kuzeeko |
An assessment of infant health issues in two rural communities in the Eastern Cape |
|
9.30-9.45 |
Ewan Tommy |
Taking a history of her story: a pharmacist’s involvement in medication reconciliation and follow-up to manage drug therapy problems in an elderly patient with Alzheimer’s dementia |
|
9.45-10.00 |
Pedzisai Makoni |
The use of experimental design for the development and validation of a stability-indicating HPLC-ECD method for the analysis of efavirenz (EFV) in dosage forms |
|
10.00-10.45 |
TEA |
|
|
THURSDAY: DAY 2 SESSION 2 Chair: Dr. B. Samant
|
||
|
10.45-11.00 |
Jameel Fakee |
Isolation and chemotaxonomic significance of polyhalogenated metabolites from Plocamium rigidum |
|
11.00-11.15 |
Ian Jordaan |
Multidrug resistant Mycobacterium tuberculosis meningitis and cryptococcal meningitis co-infection in a HIV-positive patient: A case study in timeous diagnosis and treatment considerations |
|
11.15- 11.30 |
Catherine Luyt |
Faecal source tracking and public health |
|
11.30-12.00 |
Jacqueline Jooste |
Introducing concepts of clinical audit process in advanced clinical pharmacy practice |
|
12.00-12.15 |
Ruth Lancaster |
Paying the Piper: Impact of prescribing practice on cost |
|
12.15-12.30 |
Theoneste Umumararungu |
Design and synthesis of rigid peptidomimetics displaying characteristic features of the polyproline II helix against tuberculosis |
|
12.30-12.45 |
Jane Riddin |
Use of medication reconciliation to identify medication discrepancies at time of admission to a surgical ward – a pilot study |
|
12.45-13.00 |
Sonal Patel |
Information about medicines: “Patients don’t know what they should know” |
|
13.00-14.00 |
LUNCH |
|
|
THURSDAY: DAY 2 SESSION 3 Chair: Mr J. Fakee |
||
|
14.00-14.45 |
Guest speaker: Dr. Johan Svenson |
MabCent- Arctic Marine Biprospecting in Norway |
|
14.45-15.00 |
Ya-Ying Wang |
A case study: management of warfarin toxicity |
|
15.00-15.15 |
Chikomborero est Chakaingesu |
Synthesis of naphthoquinone derivatives as potential anti-trypanosomal agents against Human African Trypanosomiasis (sleeping sickness) |
|
15.15-15.30 |
Judith Wilson |
Perindopril DUE |
|
15.30-16.00 |
TEA |
|
|
THURSDAY: DAY 2 SESSION 4 Chair: Ms N. Dukhi
|
||
|
16.00-16.15 |
Chiluba Mwila |
Effect of HPMC grade, MCC grade and lactose type on swelling, erosion and nevirapine release characteristics from sustained release matrix tablets |
|
16.15-16.30 |
Vishen Jugathpal
|
Comparison of a sliding-scale regimen with a supplemental-dose regimen at the Port Elizabeth Hospital Complex |
|
16.30-16.45 |
Emmanuel Olawode |
Creating a Library of Novel Fmoc-2-aminoalkylthiazole-4-carboxylic acid of L-amino acids for Solid Phase Peptide Synthesis of potentially Bioactive Thiazole Peptides |
|
16.45-17.00 |
Lindsay Dillon |
Warfarin management in patients with venous thromboembolism while on concomitant therapy for the treatment of tuberculosis |
|
FRIDAY: DAY 3
SESSION 1 Chair: Mr M. Chiwakata
|
||
|
8.30-8.45 |
ANNOUNCEMENTS |
|
|
8.45-9.00 |
Byron Mubaiwa |
The isolation of a sesquiterpene lactone with radical scavenging activity from Brachylaena elliptica |
|
9.00-9.15 |
Mlungisi Ndlovu |
Reducing inappropriate prescribing in geriatrics |
|
9.15-9.30 |
Tawanda Dube |
Development and assessment of immediate release tenofovir disoproxil fumarate capsules for adult use. |
|
9.30-9.45 |
Renier Coetzee |
Children, pills and pharmacists: how safe are we? |
|
9.45-10.00 |
Mutenta Nyambe |
An investigation of the potential anti-diabetic activity of anti-oxidant compounds derived from Sargassum heterophyllum |
|
10.00-10.45 |
TEA |
|
|
FRIDAY: DAY
SESSION 2 Chair: Miss C. Luyt
|
||
|
10.45-11.00 |
Ashmita Ramanah |
Development and validation of a stability indicating RP-HPLC method for the determination of ketoconazole (KTZ) in pharmaceutical dosage forms |
|
11.00-11.15 |
Denzel Mubare |
Phytochemical studies on Pelargonium sidoides and Pelargonium reniforme |
|
11.15-11.30 |
Nocawe Mdazuka |
MD, what exactly are you…are you are psychological or sociological…? |
|
11.30-12.00 |
Clarris Magadza |
Regulation of Traditional Health Practice in South Africa: The Influence of Agency |
|
12.00-12.15 |
Nazley Fakir |
Chlorpromazine verses Haloperidol in the treatment of postpartum psychosis: A Case Study in the process followed to resolve a medication error by using a medical/organizational system change approach |
|
12.15-12.30 |
Neeran Jooste |
Investigation into the Usage of Indomethacin Suppositories at Frere Hospital Outpatient Departments |
|
12.30-12.45 |
CLOSING ADDRESS: PROF. R.B. WALKER |
|
